Yayınlar & Eserler

Yayın Ağı
Makaleler 61
Tümü (61)
SCI-E, SSCI, AHCI (36)
SCI-E, SSCI, AHCI, ESCI (58)
ESCI (21)
Scopus (61)
TRDizin (25)

1. Clinical Outcomes Following Transition from ICS/LABA to Single-Inhaler Triple Therapy in Patients with Uncontrolled Asthma: A Real-World Cohort Study

Yağdıran M., AKSU K.
Medicina (Lithuania) , cilt.62, sa.8, 2026 (SCI-Expanded, Scopus)

2. Vitamin B12 desensitization and provocation: Ten-year clinical experience

Dindar Çelik F., AKSU K., Göktürk Ö., Karahan Y., Baştuğ İnan N. B., Uslu B., et al.
World Allergy Organization Journal , cilt.19, sa.7, 2026 (SCI-Expanded, Scopus)

3. Biologic Switching in Patients with Severe Asthma: Effects on Exacerbations, Corticosteroid Use and Lung Function

Dindar Çelik F., AKSU K.
Journal of Clinical Medicine , cilt.15, sa.11, 2026 (SCI-Expanded, Scopus)

4. Phenotypic characteristics of exacerbations in severe asthmatics receiving biological agent treatment

Tuğlu H. Ç., AKSU K., Akkale Ö., Telli O., Çelik F. D., Yağdıran M., et al.
Allergologia et Immunopathologia , cilt.54, sa.2, ss.51-56, 2026 (SCI-Expanded, Scopus) Creative Commons License

5. Hypersensitivity reactions with proton pump inhibitors: five years of clinical experience

Yağdıran M., AKSU K., Akkale Ö., Tuğlu H. Ç., Telli O., Çelik F. D., et al.
Allergologia et Immunopathologia , cilt.54, sa.2, ss.70-75, 2026 (SCI-Expanded, Scopus) Creative Commons License

6. Assessment of the efficacy and medication adherence of fluticasone propionate–salmeterol combination delivered via a capsule-based dry powder inhaler in asthmatic patients

Göktürk Ö., Utkusavaş A., Akıncı M., AKSU K.
Allergologia et Immunopathologia , cilt.54, sa.4, ss.114-119, 2026 (SCI-Expanded, Scopus)

7. A case of herpes zoster following the first dose of benralizumab

AKSU K., Telli O., Yağdıran M., Çelik F. D., Tuğlu H. Ç., Göktürk Ö.
Allergologie Select , cilt.10, ss.49-51, 2026 (ESCI, Scopus)

8. Sinonasal outcomes in patients with chronic rhinosinusitis with nasal polyps and severe asthma treated with mepolizumab: A real-life study

Vural Solak G. T., AKSU K., Erçelebi D. Ç., Demir Ş., Yağdıran M., Çelik F. D., et al.
Allergologia et Immunopathologia , cilt.54, sa.1, ss.123-129, 2026 (SCI-Expanded, Scopus) Creative Commons License

9. Asthma data in Türkiye between 2016 and 2022: a nationwide descriptive and observational study covering the entire adult population

AKSU K., Solak G. T. V., ATA N., Türkkani M. H., Ülgü M. M., Birinci Ş., et al.
Turkish Journal of Medical Sciences , cilt.56, sa.2, ss.509-517, 2026 (SCI-Expanded, Scopus, TRDizin)

10. Does the teicoplanin skin test predict IgE-mediated hypersensitivity?

İnan N. B. B., Göktürk Ö., Karahan Y., AKSU K.
Allergologie Select , cilt.10, ss.98-100, 2026 (ESCI, Scopus)

11. An Investigation of Loneliness in Patients with Severe Asthma

Yağdıran M., AKSU K., Çelik Tuğlu H., Akkale Ö., Dindar Çelik F., Telli O., et al.
Bratislava Medical Journal , cilt.126, sa.10, ss.2716-2720, 2025 (SCI-Expanded, Scopus)

12. The Feasibility and Impact of Implementing Interventions to Reduce Short-Acting β2-Agonist Over-Reliance in Asthma: An Expert Opinion

Nannini L., Aisanov Z., AKSU K., Alzaabi A., Antúnez M., Cañizares-Fernandez L., et al.
Advances in Therapy , cilt.42, sa.10, ss.4797-4823, 2025 (SCI-Expanded, Scopus)

13. The impact of aeroallergen sensitization on bronchial hyperreactivity in adults

Telli O., AKSU K., Akkale O., Tuglu H. C., Celik F. D., Yagdiran M., et al.
Allergy and Asthma Proceedings , cilt.46, sa.5, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

14. The effect of biological agent use on symptoms in patients diagnosed with NSAID-Exacerbated Respiratory Disease (NERD) L'effet de l'utilisation des biothérpies chez les patients présentant une pathologie respiratoire exacerbée par les AINS

Çelik Tuğlu H., AKSU K., Telli O., Dindar Çelik F., Yağdıran M., Akkale Ö., et al.
Revue Francaise d'Allergologie , cilt.65, sa.4, 2025 (SCI-Expanded, Scopus)

15. Evaluating the Effect of Drug Provocation Tests on Anxiety and Hopelessness Levels

Vural Solak G. T., AKSU K., Yağdıran M., Dindar Çelik F., Akkale Ö., Telli O., et al.
Medicina (Lithuania) , cilt.61, sa.6, 2025 (SCI-Expanded, Scopus) Creative Commons License

16. The experiences of ferric carboxymaltose desensitization and provocation

Dindar Çelik F., AKSU K., Akkale Ö., Çelik Tuğlu H., Yağdıran M., Telli O., et al.
World Allergy Organization Journal , cilt.18, sa.2, 2025 (SCI-Expanded, Scopus)

17. Successful desensitization with FVIII/Von Willebrand Factor concentrate in Type III Von Willebrand Disease

Solak G. T. V., KÖYCÜ BUHARİ G., NAZİK BAHÇECİOĞLU S., Gültuna S., Erçelebi D. Ç., Demir Ş., et al.
Allergologia et Immunopathologia , cilt.53, sa.6, ss.141-145, 2025 (SCI-Expanded, Scopus) Creative Commons License

18. Analysis of Patients Undergoing Metronidazole Challenge Testing: Real-Life Data

Telli O., AKSU K., Akkale O., Celik Tuglu H., Yagdiran M., Dindar Celik F., et al.
Asthma Allergy Immunology , cilt.23, sa.1, ss.64-69, 2025 (ESCI, Scopus, TRDizin) Creative Commons License

19. Does mepolizumab ease intestinal parasitic infections?

AKSU K., Çelik Tuğlu H., Yağdıran M., Dindar Çelik F., Akkale Ö., Telli O.
Eurasian Journal of Pulmonology , cilt.27, sa.1, ss.59-61, 2025 (ESCI, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma

20. Mepolizumab and pregnancy: A case of severe eosinophilic asthma in a patient who conceived during mepolizumab treatment

AKSU K., Yağdıran M., Çelik Tuğlu H., Telli O., Akkale Ö., Dindar Çelik F.
Eurasian Journal of Pulmonology , cilt.27, sa.1, ss.62-64, 2025 (ESCI, Scopus, TRDizin) Creative Commons License

21. Efficacy of tiotropium bromide on spirometric measurements and control of asthma in real life: data from a 1-year clinical follow-up

Dindar Çelik F., AKSU K., Çelik E., Çelik Tuğlu H., Yağdıran M., Akkale Ö., et al.
Journal of Asthma , cilt.62, sa.9, ss.1584-1590, 2025 (SCI-Expanded, Scopus)

22. Rapid drug desensitization to taxanes: a descriptive study from Turkey

Yeşilkaya S., AKSU K., Vural Solak G. T., Demir Ş., Topel M., Erçelebi D. Ç., et al.
Journal of Oncology Pharmacy Practice , cilt.30, sa.8, ss.1358-1363, 2024 (SCI-Expanded, Scopus)

23. Economic burden of short-acting beta-2 agonist (SABA) overuse among asthma patients in Türkiye: a cost analysis with respect to the updated GINA treatment recommendations

YORGANCIOĞLU A. A., AKSU K., Cura C., Yaman Y., Dinç M., Malhan S., et al.
BMC Pulmonary Medicine , cilt.24, sa.1, 2024 (SCI-Expanded, Scopus)

24. Demographic and Asthma-Related Characteristics of Asthmatics Using Pressurized Metered Dose Inhalers and Dry Powder Inhalers

AKSU K., Vural Solak G. T., Mutlu L. C., MUTLU P., Vayısoğlu Şahin G., Erdem Türe E., et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery , cilt.37, sa.6, ss.346-350, 2024 (SCI-Expanded, Scopus)

25. Variables predicting clinical remission among adults with severe asthma treated with biologic agents

Yeşilkaya S., AKSU K., Solak G. T. V., Akkale Ö., Telli O., Tuğlu H. Ç., et al.
European Annals of Allergy and Clinical Immunology , cilt.56, sa.5, ss.219-226, 2024 (ESCI, Scopus)

26. Non-Immediate Type Hypersensitivity Reactions with First-Line Antituberculosis Drugs and Diagnostic Patch Testing

KÖYCÜ BUHARİ G., NAZİK BAHÇECİOĞLU S., Gultuna S., Cuhadar Ercelebi D., Demir S., Celik Tuglu H., et al.
Asthma Allergy Immunology , cilt.22, sa.2, ss.181-188, 2024 (ESCI, Scopus, TRDizin) Creative Commons License

27. The long-term outcomes of mepolizumab treatment at 100 mg dose on idiopathic chronic eosinophilic pneumonia: A real-life experience

Solak G. T. V., AKSU K., Akkale O., Telli O., Tuglu H. C., Celik F. D., et al.
Allergy and Asthma Proceedings , cilt.45, sa.4, 2024 (SCI-Expanded, Scopus)

28. A case of allergic bronchopulmonary aspergillosis in a patient with a history of pulmonary tuberculosis and chronic obstructive pulmonary disease (COPD)

Telli O., Çelik Tuğlu H., Yağdıran M., Akkale Ö., Dindar Çelik F., AKSU K.
Eurasian Journal of Pulmonology , cilt.26, sa.2, ss.136-139, 2024 (ESCI, Scopus, TRDizin)

29. Propolis: Is it harmless to the extent that it is natural?

Çelik Tuğlu H., Dindar Çelik F., Yağdıran M., Telli O., Akkale Ö., AKSU K.
Eurasian Journal of Pulmonology , cilt.26, sa.2, ss.144-146, 2024 (ESCI, Scopus, TRDizin)

30. Oral Provocation with Alternative Medicine in H1-Antihistamine Drug Allergies

Celik Tuglu H., AKSU K., Yagdiran M., Dindar Celik F., Akkale O., Telli O., et al.
Asthma Allergy Immunology , cilt.22, sa.3, ss.309-315, 2024 (ESCI, Scopus, TRDizin) Creative Commons License

31. A rare condition: Montelukast allergy

Çelik F. D., Tuğlu H. Ç., Yağdıran M., Akkale Ö., Telli O., AKSU K.
Eurasian Journal of Pulmonology , cilt.26, sa.1, ss.70-72, 2024 (ESCI, Scopus, TRDizin) Creative Commons License

32. What is the Best Way to Diagnose Possible Asthma Patients with Negative Bronchodilator Reversibility Tests?

Başa Akdoğan B., Koca Kalkan I., KÖYCÜ BUHARİ G., Özdedeoğlu Ö., ATEŞ H., AKSU K., et al.
Journal of Asthma and Allergy , cilt.17, ss.113-122, 2024 (SCI-Expanded, Scopus)

33. Results of omalizumab treatment in chronic eosinophilic pneumonia: Real-life data Kronik eozinofilik pnömonide omalizumab tedavisinin sonuçları: Gerçek yaşam verileri

Başa Akdoğan B., AKSU K., Koca Kalkan İ., KÖYCÜ BUHARİ G., Özdedeoğlu Ö., ATEŞ H., et al.
Tuberkuloz ve Toraks , cilt.72, sa.1, ss.71-81, 2024 (ESCI, Scopus, TRDizin) Creative Commons License

34. Hypersensitivity reactions with first-line antituberculosis drugs and outcomes of rapid desensitizations

KÖYCÜ BUHARİ G., Oner Erkekol F., Koca Kalkan I., ATEŞ H., Vural Solak G. T., Akkale O., et al.
World Allergy Organization Journal , cilt.17, sa.1, 2024 (SCI-Expanded, Scopus)

35. Implementation of written asthma action plan among asthma patients in Türkiye: a multicenter, cross-sectional, descriptive study

AKSU K., Vural Solak G. T., MUTLU P., Mutlu L. C., Vayişoğlu Şahin G., Yormaz B., et al.
Turkish Journal of Medical Sciences , cilt.54, sa.6, ss.1281-1285, 2024 (SCI-Expanded, Scopus, TRDizin)

36. A descriptive study evaluating quality of life and factors affecting it in adult asthmatics Une étude descriptive évaluant la qualité de vie et les facteurs qui l'affectent chez les asthmatiques adultes

Solak G. V., AKSU K., Erçelebi D. Ç., Topel M., Yeşilkaya S., DEMİR Ş., et al.
Revue Francaise d'Allergologie , cilt.63, sa.7, 2023 (SCI-Expanded, Scopus)

37. Platin desensitizations in thoracic malignancies and risk factors for breakthrough reactions

KÖYCÜ BUHARİ G., Kalkan İ. K., ATEŞ H., NAZİK BAHÇECİOĞLU S., Demir Ş., Yeşilkaya S., et al.
Allergologia et Immunopathologia , cilt.51, sa.2, ss.130-136, 2023 (SCI-Expanded, Scopus) Creative Commons License

38. Characteristics of adverse reactions due to subcutaneous allergen immunotherapy applied between 2011-2021: Single center experience 2011-2021 yılları arasında uygulanan subkutan alerjen immünoterapisine bağlı gelişen yan etkilerin özellikleri: Tek merkez deneyimi

Vural Solak G. T., AKSU K., Solak Y., Demir Ş., Çuhadar Erçelebi D., KÖYCÜ BUHARİ G., et al.
Tuberkuloz ve Toraks , cilt.71, sa.4, ss.356-366, 2023 (ESCI, Scopus, TRDizin) Creative Commons License

39. Short-acting β2-agonist prescription patterns in patients with asthma in Turkey: results from SABINA III

YORGANCIOĞLU A. A., AKSU K., Naycı S. A., EDİGER D., MUNGAN V. D., Gül U., et al.
BMC Pulmonary Medicine , cilt.22, sa.1, 2022 (SCI-Expanded, Scopus)

40. Expert Opinion on Practice Patterns in Mild Asthma After the GINA 2019 Updates: A Major Shift in Treatment Paradigms from a Long-Standing SABA-Only Approach to a Risk Reduction–Based Strategy with the Use of Symptom-Driven (As-Needed) Low-Dose ICS/LABA

Ozseker Z. F., AKSU K., Mutlu L. C., MUTLU P., KÖKTÜRK N.
Current Allergy and Asthma Reports , cilt.22, sa.10, ss.123-134, 2022 (SCI-Expanded, Scopus)

41. Successful desensitization under antihistamine suppression in a case with urticaria due to osimertinib

Vural Solak G. T., AKSU K., Topel M., Çuhadar Erçelebi D., Yeşilkaya S., Demir Ş., et al.
Journal of Oncology Pharmacy Practice , cilt.28, sa.6, ss.1454-1457, 2022 (SCI-Expanded, Scopus)

42. Could FEF 25–75 levels or blood eosinophil counts predict the presence or absence of bronchial hyperreactivity?

AKSU K., Firincioglulari A., Erdem E., AKSU F.
Eurasian Journal of Pulmonology , cilt.24, sa.1, ss.18-22, 2022 (Scopus, TRDizin)

43. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey

DURUSU TANRIÖVER M., Doğanay H. L., AKOVA M., GÜNER H. R., AZAP A., AKHAN S., et al.
The Lancet , cilt.398, sa.10296, ss.213-222, 2021 (SCI-Expanded, Scopus)

44. Real-life adherence to subcutaneous immunotherapy: What has changed in the era of the COVID-19 pandemic

Koca Kalkan I., ATEŞ H., AKSU K., Yesilkaya S., Topel M., Cuhadar Ercelebi D., et al.
World Allergy Organization Journal , cilt.14, sa.7, 2021 (SCI-Expanded, Scopus)

45. Programmed death ligand-1 expression levels, clinicopathologic features, and survival in surgically resected sarcomatoid lung carcinoma

AĞAÇKIRAN Y., AKSU F., AKYÜREK N., Ercan C., DEMİRÖZ Ş. M., AKSU K.
Asia-Pacific Journal of Clinical Oncology , cilt.17, sa.3, ss.280-288, 2021 (SCI-Expanded, Scopus) Creative Commons License

46. COVID-19 in a patient with severe asthma using mepolizumab

AKSU K., Yesilkaya S., Topel M., Turkyilmaz S., Ercelebi D. C., Oncul A., et al.
Allergy and Asthma Proceedings , cilt.42, sa.2, ss.55-57, 2021 (SCI-Expanded, Scopus)

47. EVALUATION OF ANXIETY IN INDIVIDUALS WITH END-STAGE LUNG DISEASE DURING COVID-19 PANDEMIC COVID-19 PANDEMİSİ SÜRECİNDE SON DÖNEM AKCİĞER HASTALIĞI OLAN BİREYLERDE KAYGININ DEĞERLENDİRİLMESİ

YILDIZ M., Beyoglu M. A., Şahin M. F., AKSU K.
Ankara Medical Journal , cilt.21, sa.4, ss.594-604, 2021 (Scopus, TRDizin) Creative Commons License

48. Clinician’s perspective regarding medication adherence in patients with obstructive lung diseases and the impact of COVID-19

YILDIZ M., AKSU F., Yıldız N., AKSU K.
Revista da Associacao Medica Brasileira , cilt.67, ss.97-101, 2021 (SCI-Expanded, Scopus) Creative Commons License

49. COVID-19 in patients with severe asthma using biological agents

AKSU K., Demir Ş., Topel M., Yeşilkaya S., ATEŞ H., Koca Kalkan İ., et al.
Tuberkuloz ve Toraks , cilt.69, sa.3, ss.433-436, 2021 (ESCI, Scopus, TRDizin) Creative Commons License

50. Mycobacterium abscessus infection management: Macrolide and quinolone desensitization Mycobacterium abscessus enfeksiyonu yönetimi: Makrolid ve kinolon desensitizasyonu

AKSU K., Çuhadar Erçelebi D., ÖZKARA Ş., Türkyilmaz S., Koca Kalkan İ., Özdedeoğlu Ö., et al.
Tuberkuloz ve Toraks , cilt.69, sa.3, ss.399-402, 2021 (ESCI, Scopus, TRDizin) Creative Commons License

51. Can fractional exhaled Nitric Oxide with blood eosinophil count have a place in the diagnostic algorithm for Asthma?

Koca Kalkan İ., KÖYCÜ BUHARİ G., ATEŞ H., Başa Akdoğan B., Özdedeoğlu Ö., AKSU K., et al.
Asthma Allergy Immunology , cilt.19, sa.2, ss.100-109, 2021 (ESCI, Scopus, TRDizin)

52. Rare atopy in COVID-19 patients or COVID-19 famine in atopic patients?

Naziroğlu T., AKSU K.
Dermatologic Therapy , cilt.34, sa.1, 2021 (SCI-Expanded, Scopus)

53. A case of COVID-19 pneumonia presenting with acute urticaria

Naziroğlu T., Sözen S., Özkan P., Şeker S., AKSU K.
Dermatologic Therapy , cilt.33, sa.4, 2020 (SCI-Expanded, Scopus)

54. Aerosol Medication Use in COVID-19 Pandemic

Topel M., AKSU K.
Asthma Allergy Immunology , cilt.18, sa.2, ss.110-112, 2020 (ESCI, Scopus, TRDizin)

55. Covid-19: Normalleşme sürecinde alerji kliniği

AKSU K.
Tuberkuloz ve Toraks , cilt.68, sa.2, ss.200-204, 2020 (ESCI, Scopus, TRDizin) Creative Commons License

56. Successful desensitization with ferric carboxymaltose

Özdedeoǧlu Ö., AKSU K., Akdoǧan B., ATEŞ H., KÖYCÜ BUHARİ G., Kalkan I., et al.
Asthma Allergy Immunology , cilt.18, sa.1, ss.51-53, 2020 (ESCI, Scopus, TRDizin)

57. COVID-19 PANDEMIA AND INFLUENZA SEASON COVID-19 PANDEMİSİ VE İNFLUENZA SEZONU

AKSU K.
Ankara Medical Journal , cilt.20, sa.4, ss.1115-1117, 2020 (Scopus, TRDizin) Creative Commons License

58. OCUPATIONAL ASTHMA AND RHINITIS AMONG HEALTH CARE WORKERS IN TERTIARY HEALTH CARE CENTERS ÜÇÜNCÜ BASAMAK SAĞLIK ÇALIŞANLARINDA MESLEKSEL RİNİT VE ASTIM SORGULAMASI

Dursun A. B., AKSU F., Bayiz H., AKSU K.
Ankara Medical Journal , cilt.20, sa.1, ss.196-204, 2020 (Scopus, TRDizin) Creative Commons License

59. What is the role of montelukast in asthma treatment? Astım tedavisinde montelukastın yeri nedir?

AKSU K., AKSU K., AKSU F., AKSU F.
Tuberkuloz ve Toraks , cilt.68, sa.3, ss.328-330, 2020 (ESCI, Scopus, TRDizin) Creative Commons License

60. Does spirometric tests meet the acceptability criteria? Data from a tertiary chest hospital in Turkey Spirometrik incelemeler kabul edilebilirlik kriterlerini sağlıyor mu? Türkiye’de üçüncü basamak göğüs hastalıkları hastanesi verisi

AKSU K., Firincioğlulari A., AKSU F.
Tuberkuloz ve Toraks , cilt.68, sa.2, ss.112-117, 2020 (ESCI, Scopus, TRDizin)

61. The comprehensive evaluation of latent tuberculosis infection in health care workers and of patients with active tuberculosis using TST, ELISA, and ELISPOT methods Hastane çalışanlarında latent tüberküloz enfeksiyonunun ve aktif tüberkülozlu hastaların TDT, ELISA ve ELISPOT yöntemleriyle kapsamlı deǧerlendirilmesi

ŞİMŞEK H., Alpar S. M., AKSU K., AKSU F., Ceyhan I., CESUR S., et al.
Turkish Journal of Medical Sciences , cilt.40, sa.4, ss.585-591, 2010 (SCI-Expanded, Scopus, TRDizin)
Metrikler

Yayın

61

Yayın (WoS)

58

Yayın (Scopus)

61

H-İndeks (WoS)

8

Atıf (Scopus)

965

H-İndeks (Scopus)

8

Atıf (TrDizin)

5

H-İndeks (TrDizin)

1

Atıf (Diğer Toplam)

5

Proje

1

Açık Erişim

23
BM Sürdürülebilir Kalkınma Amaçları
SDG 3: AMAÇ 3: SAĞLIKLI BİREYLER